Debt-to-equity of Insight Molecular Diagnostics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Insight Molecular Diagnostics Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Insight Molecular Diagnostics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -1970%, a 688% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1970% -2305% -688% 30 Sep 2025
Q2 2025 2370% +2156% +1008% 30 Jun 2025
Q1 2025 692% +529% +326% 31 Mar 2025
Q4 2024 674% +553% +458% 31 Dec 2024
Q3 2024 335% +218% +186% 30 Sep 2024
Q2 2024 214% +103% +92% 30 Jun 2024
Q1 2024 163% +51% +46% 31 Mar 2024
Q4 2023 121% -2% -1.4% 31 Dec 2023
Q3 2023 117% -4% -3.2% 30 Sep 2023
Q2 2023 111% +1% +1.1% 30 Jun 2023
Q1 2023 111% +10% +10% 31 Mar 2023
Q4 2022 123% +53% +76% 31 Dec 2022
Q3 2022 121% +66% +120% 30 Sep 2022
Q2 2022 110% +59% +114% 30 Jun 2022
Q1 2022 101% +58% +136% 31 Mar 2022
Q4 2021 70% +6% +9.6% 31 Dec 2021
Q3 2021 55% -1% -1.1% 30 Sep 2021
Q2 2021 51% +8% +18% 30 Jun 2021
Q1 2021 43% +12% +41% 31 Mar 2021
Q4 2020 64% +48% +317% 31 Dec 2020
Q3 2020 56% +39% +238% 30 Sep 2020
Q2 2020 43% +20% +87% 30 Jun 2020
Q1 2020 30% -6% -16% 31 Mar 2020
Q4 2019 15% -72% -83% 31 Dec 2019
Q3 2019 16% -67% -80% 30 Sep 2019
Q2 2019 23% -61% -73% 30 Jun 2019
Q1 2019 36% -56% -61% 31 Mar 2019
Q4 2018 87% -6% -6% 31 Dec 2018
Q3 2018 83% +10% +13% 30 Sep 2018
Q2 2018 84% +26% +44% 30 Jun 2018
Q1 2018 92% +42% +83% 31 Mar 2018
Q4 2017 93% +50% +117% 31 Dec 2017
Q3 2017 73% +38% +107% 30 Sep 2017
Q2 2017 59% 30 Jun 2017
Q1 2017 51% 31 Mar 2017
Q4 2016 43% 31 Dec 2016
Q3 2016 35% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.